rtrx – Scalper1

KaloBios CEO Shkreli Arrested For Securities Fraud

KaloBios Pharmaceuticals (KBIO) CEO Martin Shkreli was arrested on charges of securities fraud Thursday, sending KaloBios stock down more than 50% in premarket before trading was halted. The FBI detained Shkreli on charges that he’d deceived investors in his former hedge fund MSMB Capital Management about the performance of the fund, and paid their supposed returns with funds from Retrophin (RTRX), a biotech company that he headed until the board

Retrophin Hits High On Bullish Initiation Report

Small orphan-disease company Retrophin (RTRX) jumped to a new high near 26 Thursday after Leerink launched coverage of the stock with an outperform rating. Analyst Joseph Schwartz wrote that the company’s strategy depends on the pricing power of rare-disease drugs, which he says is sustainable. “Retrophin’s practice of acquiring under-appreciated therapies and raising the price many-fold has raised eyebrows; however, doing so puts the company at